-
Mashup Score: 0
For the Dutch, Estonian, French, Icelandic, Malay, Marathi, Norwegian, Portuguese, Swedish and Urdu translations of the abstract see Supplementary Materials section.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Small airway abnormalities as a marker of early lung injury: challenges ahead - PubMed - 1 year(s) ago
Small airway abnormalities as a marker of early lung injury: challenges ahead
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
We identified underutilization of outpatient palliative care services within stage IV NSCLC patients. Many patients with NSCLC experience hospitalization the last month of life and in-hospital death.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 1The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study - PubMed - 1 year(s) ago
Older, multimorbid patients may derive QALY gains from adjuvant chemotherapy after NSCLC surgery. These results help extend existing clinical trial data to specific unstudied, high-risk populations and may reduce the uncertainty regarding adjuvant chemotherapy use in these patients.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations - PubMed - 1 year(s) ago
Researchers have made crucial advances in understanding the pathogenesis and therapeutics of non-small cell lung cancer (NSCLC), improving our understanding of lung tumor biology and progression. Although the survival of NSCLC patients has improved due to chemoradiotherapy, targeted therapy, and imm …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study - PubMed - 2 year(s) ago
The Netherlands Trial Register, NL7025.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 2
Among patients with suspected early-stage non-small cell lung cancer (NSCLC), we sought to evaluate the association of patient-clinician communication (PCC) with patient-centered outcomes (PCOs). We conducted a multicenter, prospective cohort study examining PCOs at five time points, up to 12-months …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Chemotherapy is the first choice for the treatment of cancer but it is still limited by insufficient kill efficiency and drug resistance. These problems urgently need to be overcome in a way that minimizes damage to the body. In this study, we designed the nanocomposite microparticles (NMPs) modifie …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
While epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have changed the treatment landscape for EGFR mutant (L858R and ex19del)-driven non-small-cell lung cancer (NSCLC), most patients will eventually develop resistance to TKIs. In the case of first- and second-generation TK …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations - PubMed - 2 year(s) ago
This study was novel in comprehensively investigating the clinical and molecular characteristics of patients in Chinese and Western populations, and in analyzing the factors affecting the prognosis of Chinese patients. It provided critical data for future therapies against HER2-altered NSCLC.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
#Small #airways #obstruction and its risk factors in the #Burden of #Obstructive #Lung #Disease ( #BOLD) study: a multinational cross-sectional study https://t.co/6KGHpCx9CC https://t.co/m3f5MYTTEh